Search

Your search keyword '"Jiang, Z. D."' showing total 84 results

Search Constraints

Start Over You searched for: Author "Jiang, Z. D." Remove constraint Author: "Jiang, Z. D." Database MEDLINE Remove constraint Database: MEDLINE
84 results on '"Jiang, Z. D."'

Search Results

1. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].

2. [Attention should be paid to the differentiationbetween benign paroxysmal positional vertigo and vestibular migraine].

4. Fecal calprotectin and fecal indole predict outcome of fecal microbiota transplantation in subjects with recurrent Clostridium difficile infection.

5. [Etiological analysis on patients with vertigo or dizziness].

7. Etiology of travellers' diarrhea.

8. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.

9. Measurement of Thermal Conductivity of Porcine Liver in the Temperature Range of Cryotherapy and Hyperthermia (250~315k) by A Thermal Sensor Made of A Micron-Scale Enameled Copper Wire.

12. DETERMINATION OF CONVECTIVE HEAT TRANSFER COEFFICIENT AT THE OUTER SURFACE OF A CRYOVIAL BEING PLUNGED INTO LIQUID NITROGEN.

13. Mild maturational delay of the brainstem at term in late preterm small-for-gestation age babies.

14. Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy.

15. First Report of Brown Spot Disease Caused by Neoscytalidium dimidiatum on Hylocereus undatus in Guangdong, Chinese Mainland.

16. Characterization of norovirus-associated traveler's diarrhea.

17. In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas.

19. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

20. Rifaximin: in vitro and in vivo antibacterial activity--a review.

21. Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci.

22. One-third of term babies after perinatal hypoxia-ischaemia have transient hearing impairment: dynamic change in hearing threshold during the neonatal period.

23. Brainstem auditory-evoked responses to different rates of clicks in small-for-gestational age preterm infants at term.

24. Intestinal immunoglobulin a response to naturally acquired enterotoxigenic Escherichia coli in US travelers to an endemic area of Mexico.

25. Comparison of brainstem auditory evoked responses recorded at different presentation rates of clicks in term neonates after asphyxia.

26. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.

27. Hearing impairment in preterm very low birthweight babies detected at term by brainstem auditory evoked responses.

28. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations.

29. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.

30. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions.

31. Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico.

32. Maximum length sequence brainstem auditory evoked responses in term neonates who have perinatal hypoxia-ischemia.

33. In vitro activity and fecal concentration of rifaximin after oral administration.

34. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers.

35. Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea.

36. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997.

37. 5-Lipoxygenase-derived oxylipins from the red alga Rhodymenia pertusa.

38. Etiology of travelers' diarrhea on a Caribbean island.

39. Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique.

40. Brainstem auditory evoked response recorded using maximum length sequences in term neonates.

41. Conductive hearing loss produces a reversible binaural hearing impairment.

42. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin.

43. Lobophorins A and B, new antiinflammatory macrolides produced by a tropical marine bacterium.

44. Outcome of brain stem auditory electrophysiology in children who survive purulent meningitis.

45. Etiology of outpatient pediatric nondysenteric diarrhea: a multicenter study in the United States.

46. Combined carotid endarterectomy and coronary artery bypass: immediate and long-term results.

47. Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.

48. Immaturity of electrophysiological response of the neonatal auditory brainstem to high repetition rates of click stimulation.

49. Screening systems for detecting inhibitors of cell wall transglycosylation in Enterococcus. Cell wall transglycosylation inhibitors in Enterococcus.

50. Maturation of peripheral and brainstem auditory function in the first year following perinatal asphyxia: a longitudinal study.

Catalog

Books, media, physical & digital resources